101 related articles for article (PubMed ID: 27916717)
1. Is LukS-PV a novel experimental therapy for leukemia?
Shan W; Ma X; Deng F
Gene; 2017 Feb; 600():44-47. PubMed ID: 27916717
[TBL] [Abstract][Full Text] [Related]
2. LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells.
Bu S; Xie Q; Chang W; Huo X; Chen F; Ma X
Int J Biochem Cell Biol; 2013 Aug; 45(8):1531-7. PubMed ID: 23702031
[TBL] [Abstract][Full Text] [Related]
3. LukS-PV, a component of Panton-Valentine leukocidin, exerts potent activity against acute myeloid leukemia in vitro and in vivo.
Shan W; Bu S; Zhang C; Zhang S; Ding B; Chang W; Dai Y; Shen J; Ma X
Int J Biochem Cell Biol; 2015 Apr; 61():20-8. PubMed ID: 25601295
[TBL] [Abstract][Full Text] [Related]
4. LukS-PV induces differentiation by activating the ERK signaling pathway and c-JUN/c-FOS in human acute myeloid leukemia cells.
Dai C; Zhang C; Sun X; Pan Q; Peng J; Shen J; Ma X
Int J Biochem Cell Biol; 2016 Jul; 76():107-14. PubMed ID: 27102414
[TBL] [Abstract][Full Text] [Related]
5. LukS-PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor.
Zhang P; Yu WW; Peng J; Xu LF; Zhao CC; Chang WJ; Ma XL
Cancer Med; 2019 May; 8(5):2474-2483. PubMed ID: 30955242
[TBL] [Abstract][Full Text] [Related]
6. LukS-PV induces cell cycle arrest and apoptosis through p38/ERK MAPK signaling pathway in NSCLC cells.
Qiang Y; Ma F; Wang Z; Nie Z; Xu L; Ding P; Ma X
Biochem Biophys Res Commun; 2020 Jan; 521(4):846-852. PubMed ID: 31708104
[TBL] [Abstract][Full Text] [Related]
7. Construction of a LukS-PV mutant of a staphylococcal Panton-Valentine leukocidin component having a high LukS-like function.
Shimatani A; Kaneko J; Tomita T; Kamio Y
Biosci Biotechnol Biochem; 1999 Oct; 63(10):1828-30. PubMed ID: 10586512
[TBL] [Abstract][Full Text] [Related]
8. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes.
Kaneko J; Kamio Y
Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding.
Meyer F; Girardot R; Piémont Y; Prévost G; Colin DA
Infect Immun; 2009 Jan; 77(1):266-73. PubMed ID: 18838523
[TBL] [Abstract][Full Text] [Related]
10. Identification of the essential amino acid residues in lukS for the hemolytic activity of staphylococcal leukocidin towards rabbit erythrocytes.
Nariya H; Shimatani A; Tomita T; Kamio Y
Biosci Biotechnol Biochem; 1997 Dec; 61(12):2095-9. PubMed ID: 9438990
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric determination of Panton-Valentine leucocidin S component binding.
Gauduchon V; Werner S; Prévost G; Monteil H; Colin DA
Infect Immun; 2001 Apr; 69(4):2390-5. PubMed ID: 11254598
[TBL] [Abstract][Full Text] [Related]
12. Allelic variation in genes encoding Panton-Valentine leukocidin from community-associated Staphylococcus aureus.
Wolter DJ; Tenover FC; Goering RV
Clin Microbiol Infect; 2007 Aug; 13(8):827-30. PubMed ID: 17610602
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus isolated from patients with recurrent furunculosis carrying Panton-Valentine leukocidin genes represent agr specificity group IV.
Garbacz K; Piechowicz L; Barańska-Rybak W; Dąbrowska-Szponar M
Eur J Dermatol; 2011; 21(1):43-6. PubMed ID: 21233065
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of staphylococcal Panton-Valentine leukocidin in the detergent-resistant membrane microdomains on the target cells is essential for its cytotoxicity.
Nishiyama A; Isobe H; Iwao Y; Takano T; Hung WC; Taneike I; Nakagawa S; Dohmae S; Iwakura N; Yamamoto T
FEMS Immunol Med Microbiol; 2012 Dec; 66(3):343-52. PubMed ID: 22924956
[TBL] [Abstract][Full Text] [Related]
15. The matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS)-based protein peaks of 4448 and 5302 Da are not associated with the presence of Panton-Valentine leukocidin.
Szabados F; Becker K; von Eiff C; Kaase M; Gatermann S
Int J Med Microbiol; 2011 Jan; 301(1):58-63. PubMed ID: 20705506
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic and apoptotic effects of chemically synthesized silver nanoparticles loaded with recombinant Staphylococcus LukS-PV toxin.
Haghighatafshar H; Golestani Eimani B; Moazamian E; Amani J
J Biotechnol; 2023 Aug; 373():42-48. PubMed ID: 37421980
[TBL] [Abstract][Full Text] [Related]
17. LukS-PV Induces Apoptosis
Xu LF; Shi L; Zhang SS; Ding PS; Ma F; Song KD; Qiang P; Chang WJ; Dai YY; Mei Y; Ma XL
Front Oncol; 2021; 11():718791. PubMed ID: 34745943
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells.
Zhao CC; Yu WW; Qi YJ; Xu LF; Wang ZR; Qiang YW; Ma F; Ma XL
Anticancer Drugs; 2020 Mar; 31(3):223-230. PubMed ID: 31789624
[TBL] [Abstract][Full Text] [Related]
19. Panton valentine leukocidin (PVL) toxin positive MRSA strains isolated from companion animals.
Rankin S; Roberts S; O'Shea K; Maloney D; Lorenzo M; Benson CE
Vet Microbiol; 2005 Jun; 108(1-2):145-8. PubMed ID: 15917142
[TBL] [Abstract][Full Text] [Related]
20. Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model.
Siqueira JA; Speeg-Schatz C; Freitas FI; Sahel J; Monteil H; Prévost G
J Med Microbiol; 1997 Jun; 46(6):486-94. PubMed ID: 9350201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
